David Atkins, a diagnostics and healthcare executive, has been appointed chief executive officer of Congenica Ltd to lead the global expansion of its clinical genomics business. He succeeds the company’s co-founder and former CEO Tom Weaver who will continue to serve on the board of directors.
Dr Atkins was previously CEO of Synevo, a clinical diagnostic laboratory business operating across Germany and eastern Europe. He has also been an executive at the medical device and diagnostics business units at Johnson & Johnson Inc.
Dr Atkins holds a BSc and PhD from the University of East Anglia, UK, a graduate certificate in pharmacology from the University of New South Wales, Australia and an MBA from Columbia University, US.
Congenica announced the appointment on 25 January 2018.
Copyright 2018 Evernow Publishing Ltd